Clinical Trials
94 trialsSCOUT-1
AstraZeneca
DESCENT-1
A2 Biotherapeutics Inc.
DP-04
AstraZeneca
BASECAMP-1
A2 Biotherapeutics Inc.
OLIVIA
AstraZeneca
ConFeR
AbbVie
A Study of Niraparib in Patients With Ovarian Cancer in Clinical Practice
Takeda
TraveraRTGx
Travera Inc
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
OVAmiARN
ZIWIG
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Carevive Systems, Inc.
FORCE
AbbVie
SMARAGD
iOMEDICO AG
EXoPERT EMERALD Clinical Study
EXoPERT
CAMPERR
Adela, Inc
SCORE
Natera, Inc.
CCANED-CIPHER
Dysplasia Diagnostics Limited
HERGYN
Daiichi Sankyo
Clinical Pre-screening Protocol for Ovarian Cancer
Allarity Therapeutics
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese Patients
AstraZeneca
OVAL-1
AstraZeneca
OLAP
AstraZeneca
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
Alaunos Therapeutics
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
Alaunos Therapeutics
OVARD
AstraZeneca
START
Lyell Immunopharma, Inc.
BARHYSTER
Aesculap AG
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
PREFER
Labcorp Corporation of America Holdings, Inc
ChemoINtel
Pierian Biosciences
INSPIRE
Singlera Genomics Inc.
A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women with an Ovarian Mass
Cleo Diagnostics Ltd
GynRNA
ZIWIG
ROOT
Taproot Health
A Study for Post-Marketing Surveillance of Niraparib in the Treatment of Adult Participants for Approved Indications in South Korea
Takeda
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
QUANTUM
VitaMed Research LLC
RADIANT
DxTerity Diagnostics
Assessment of the Minimal Residual Disease in Ovarian Cancer From Circulating Tumor DNA and Immune Repertoire
Geneplus-Beijing Co. Ltd.
The Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical Cancer
Geneplus-Beijing Co. Ltd.
VOCAL
Venn Biosciences Corporation
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
C-PATROL
AstraZeneca
Investigating Participation Patterns Among Recurrent Ovarian Cancer Patients
Power Life Sciences Inc.
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study
Namida Lab
EMBER
Angle plc
Appraising Medical Trial Experiences of Ovarian Cancer Patients
Power Life Sciences Inc.
3D-PREDICT
KIYATEC
CADENCE
MiRXES Pte Ltd